1. (1993). Consensus Development Conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med
94:646–50.
2. Riggs, B.L., Hodgson, S.F., O’Fallon, W.M. et al. (1990). Effect of fluoride treatment on fracture rate in postmenopausal women with osteoporosis. N Engl J Med
22:802–9.
3. Eiken, P., Kolthoff, N. and Pors Nielsen, S. (1996). Effects of 10 years’ hormone replacement therapy on bone mineral content in postmenopausal women. Bone
19:1915–35.
4. Storm, T., Killerup, G., Thamsborg, G. et al. (1996). Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. J Rheumatol
23:1560–4.
5. Devogelaer, J.P., Broll, H., Correa-Potter, R. et al. (1996). Oral alendronate induced progressive increases in bone mass of the spine, hip and total body over 3 years in postmenopausal women with osteoporosis. Bone
18:141–50.